Management

CEO since 2020.

Born: 1976.

Education: Master of Science in International Business Administration from Copenhagen Business School, Denmark.

Other current roles: Advisory Board Member, SIME Clinical Al.

Previous roles in the last five years: Senior Vice President, Business Transformation and Strategy and member of the Executive Leadership Team for GN Hearing, Vice President Zimmer Biomet EMEA Spine division & President Zimmer Biomet Spine manufacturing, France.

Other relevant experience: Morten Henneveld has extensive international and medical device experience having worked as Director, Commercial Excellence for Coloplast during 2008-2012, including a period working in the USA, and then, based in Malmo, working as Managing Director, Sweden and Regional Vice President, Nordics for Biomet and subsequently Vice President, EMEA Spine for Zimmer Biomet from 2012-2016.

Holdings in OssDsign: 17 500 shares

Interim CFO since 2020.

Born: 1963.

Education: MBA, focused on Strategy/Finance from AGSM (Australian Graduate School of Management)

Other current roles: Not applicable.

Previous roles in the last five years: Interim Director Global Decision Support, GANT, CFO Bluefish Pharmaceuticals, CFO Aura Light

Other relevant experience: Anders Svensson is an experienced Chief Financial Officer with a demonstrated history from a diverse range of industries such as digital sustainability, retail, lighting and electronics manufacturing, pharmaceuticals, banking, management consulting and software development. Skilled in Business Planning and Development, Corporate Finance and Accounting, IT, Venture Capital and Strategy.

Holdings in OssDsign: Not applicable

Director of marketing & business development since 2016 and previously marketing director since 2015.

Born: 1977.

Education: Master of Science in Biotechnology Engineering at Uppsala University. Also undertook studies in entrepreneurship and economy at Uppsala University and Cornell University (Ithaca, New York, USA).

Other current roles: Not applicable.

Previous roles in the last five years: Co-founder of and global product manager at Novus Scientific AB.

Other relevant experience: Henrik Hjort has worked in life sciences since 2004 and has over ten years' experience from positions in or close to corporate governance in medtech companies. Henrik Hjort has comprehensive experience from development, corporate governance, marketing and sales in both start-ups and multi-national companies.

Holdings in OssDsign: 1 500 shares and 24 466 subscription options

Director of Technical Operations since 2018 and previously Director of Development since 2016.

Born: 1973.

Education: M.Sc. in Chemistry from Uppsala University. PhD in Inorganic Chemistry from Uppsala University. Executive MBA from Mgruppen Svenska Managementgruppen AB.

Other current roles: Not applicable.

Previous roles in the last five years: Director Project Management, Global R&D at Thermo Fisher Scientific.

Other relevant experience: Kajsa Björklund has worked in the life science industry since 2001 and has held positions as line manager, project manager and consultant, with focus on MedTech. Björklund has comprehensive experience in product development, project management, design transfer and quality work. Björklund’s role as Director Technical Operations includes responsibility for production, product supply, manufacturing technology and product development.

Holdings in OssDsign: 9,000 shares and 24,466 subscription options

Director Quality Assurance & Regulatory Affairs since 2017

Born: 1969.

Education: Master's in natural sciences and mathematics from Uppsala University.

Other current roles: Not applicable.

Previous roles in the last five years: Quality manager at Recipharm Uppsala AB.

Other relevant experience: Malin Kylberg has worked with quality assurance in the life sciences industry for the last 20 years and has comprehensive experience from quality work and regulatory issues in both pharmaceutical and medtech companies, including from senior roles with responsibilities such as being the responsible individual appointed by the Swedish Medical Products Agency.

Holdings in OssDsign: 4,000 shares and 24,466 subscription options

Clinical engineering director since 2016.

Born: 1979.

Education: Master of Science in Computer Technology Engineering at Royal Institute of Technology. PhD from Karolinska Institutet.

Other current roles: CEO of Data Vigilence Consulting AB.

Previous roles in the last five years: Director of Clinical Engineering of SciBase AB.

Other relevant work: Ulrik Birgersson has over fifteen years' experience from the life science industry and has held various roles, with a particular focus on pre-clinical and clinical studies and trial applications, including administration of applications and reporting to and communication with medical agencies such as, for example, the American pharmaceutical authority, the FDA. Birgersson was also involved in the work prior to the PMA approval that SciBase received in 2017, and was then responsible for managing pre-IDE and pre-PMA discussions with the FDA.

Holdings in OssDsign: 1,600 shares and 24,466 subscription options

VP of Commercial Operations since 2016.

Born: 1974.

Education: Bachelor of Science in pharmacology from Sheffield University, UK.

Other current roles: Board member of RedMed Consulting Ltd. and corporate director of Orthogem Ltd.

Previous roles in the last five years: Not applicable.

Other relevant experience: Rick Thomas has 20 years' experience from commercial roles in the pharmaceutical and medtech industries, initially in large organisations such as Medtronic and subsequently with companies in the start-up phase. Thomas was a member of the management group of Apatech, a British company successfully sold to Baxter for around USD 330 million in March 2010.

Holdings in OssDsign: 6,300 shares and 85,632 subscription options